Home > Formulary : Paediatric > Paediatric Chapters > 4. Nervous system >
BNSSG Paediatric Joint Formulary
4.3 Movement disorders
Last edited: 04-06-2024
4.3.1 Dystonias and other involuntary movements
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
UHBW Paediatric Dystonia guideline
Antimuscarinics
Trihexyphenidyl (TLS Amber)
Procyclidine (TLS Amber)
Other drugs used for dystonias:
Clonidine (TLS Amber)
Gabapentin (TLS Amber)
Baclofen (TLS Amber)
Haloperidol (TLS Amber)
Midazolam (TLS Amber)
Diazepam (TLS Amber)
Chloral hydrate (TLS Amber)
Clonidine patches (TLS Red)
- For patients with secondary dystonia and dyskinesia, according to UHBristol treatment pathway for Medical management of dystonia
Dopamine precursors
Co-careldopa (Sinemet®) (TLS Amber)
- For dopamine sensitive dystonia
Neurotoxins (Botulinum Toxins)
Botulinum toxin type A (Botox®, Dysport®, Xeomin®)
- NICE TA260 Botox® for use in migraine (chronic)
- Treatment of focal spasticity as per SPC
Botulinum toxin type B (Neurobloc®) (TLS Red)
- Botulinum toxin preparations are not directly interchangeable
- Botulinum toxin is not approved for treatment for hyperhidrosis. For this indication exceptional funding should be sought on a case by case basis
- To minimise the risk of errors botulinum toxin should be prescribed by brand name.
- Botulinum toxin type B is reserved for use in patients that have become tolerant to botulinum toxin type A
Others
Ataluren (TLS Red)
- NICE HST22 Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (Specialist only)
Infliximab (TLS Red)